Surgical site infection (SSI) following caesarean section is common, resulting in significant morbidity. Several factors are known to contribute to wound infection, including maternal, procedural and antibiotic factors. We sought to clarify these issues and sought opportunities to make improvements. A retrospective cohort study was performed assessing all women who underwent caesarean section in 2014 and 2015 at Wellington Hospital. Any women with culture-positive wound samples within 30 days of surgery were identified, and clinical notes reviewed.
INTRODUCTION
Caesarean section (CS) surgical site infections (CSSSI) are common (2-15% of all CS), serious and often preventable. [1] [2] [3] [4] [5] [6] SSIs result in increased morbidity, length of hospital admission, return to operating theatre and readmission rates. Recognised maternal risk factors for CSSSI include obesity [4] [5] [6] 8, 9 and gestational diabetes. 9 Procedural risk factors include emergency procedures 5, 6 and surgical technique.
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Antibiotic prophylaxis for CS was historically administered after cord clamping to reduce transmission of antibiotic to the neonate; however, recent data have shown a significant decrease in infection rate with pre-incision administration. 1, 11, 12 Data on dosing and optimal interval prior to incision of prophylactic antibiotics are limited.
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Surveillance for CSSSI has varied methods and reporting, and is not consistently performed in the Australasian setting. 1, [14] [15] [16] In our centre, passive laboratory surveillance has been conducted retrospectively, using growth of Staphylococcus aureus in a post-operative wound sample, since 2010. One aim of this study was to establish how representative such simplified methods of surveillance are. Additionally, we aimed to identify groups of women at risk of CSSSI to assist the creation of a prevention care bundle.
MATERIALS AND METHODS

Subjects and setting
A retrospective cohort study was performed from January 2014
to December 2015 at Wellington Regional Hospital, New Zealand, 
Clinical definitions
Height and weight were recorded at the antenatal booking visit to calculate body mass index (BMI). Booking BMI was used rather than BMI at CS as it was more reliably recorded, resulting in a more complete and reliable dataset. Obesity was defined as booking BMI ≥ 30. Women were classified as diabetic if they had either pre-existing diabetes mellitus, newly diagnosed type 1 or 2 diabetes mellitus, or gestational diabetes mellitus. 17 Maternal age was considered as advanced if ≥35 years at the time of CS.
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Ethnicity was self-determined by women at antenatal booking, and was grouped as European, Māori, Samoan, Indian, Other
Asian and Other.
Pregnancy factors included preterm births (gestation <37/40 at delivery), small or large for gestational age (<10th centile or >90th centile, respectively). Procedural factors included emergency versus elective CS, after-hours versus daytime-hours delivery and consultant obstetrician versus registrar as primary surgeon.
Drug, dose and timing of preoperative antibiotic administration was recorded, and whether dose was adjusted for weight or BMI.
The institutional policy recommended increasing from a 2 to 3 g dose of cefazolin for women weighing 120 kg or greater; 19 recent research suggests that increased dosing where BMI ≥ 30 may be more appropriate.
20,21
The study received ethical approval from the Capital and Coast
District Health Board's Clinical Research and Audit Committee. 
Definition and identification of infections
Identification and classification of pathogens
Standard microbiology techniques were used in the laboratory.
Organisms were identified to the species level if they had colonial morphology consistent with S. aureus or beta-haemolytic streptococci. Only predominant or pure growth of coliforms were identified and reported, and anaerobes were described predominately based on colonial morphology, culture requirements and Gram stain appearances.
Organisms were classified into three categories as follows:
S. aureus and beta-haemolytic streptococci; anaerobes; other, which included Gram negative rods. Commensal organisms such as coagulase-negative staphylococci, coryneform bacteria and other skin organisms were regarded not to be significant.
Statistical analysis
Statistical analyses were carried out using Microsoft Excel 2010, Where particular ethnic groups were identified as having higher ORs for infection, post hoc analysis was carried out to control for BMI using Mantel-Haenszel stratification of BMI to strata of <30, 30-40 and ≥40. CIs were calculated using the methods proposed by Clayton and Hills.
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RESULTS
A total of 2231 CS were performed in the study period. The demographic details of the entire group are shown in Table 1 .
Swabs were taken from 162 women within 30 days of surgery Fifteen women (0.67%) required readmission related to CSSSI.
Eight women (0.36%) required return to the operating theatre for procedures relating to SSI. Overall, with the assumptions above, up to 7.3% of women undergoing CS developed superficial (ie had a wound prompting a swab to be taken), and 0.4% deep wound infections, respectively.
Antibiotic data were collected from the anaesthetic administration system, which was introduced in December 2014, therefore data was only available for part of the study period.
Ethnicity
Women identifying as Māori and Samoan had significantly in- Figure 1 ; BMI stratification tables are given in the Tables S1 and S2 .
Potential risk factors and ORs
Obesity (booking BMI ≥ 30) was associated with a significantly in- Tables S1 and S2 .
Antibiotic administration
Complete antibiotic data were available for 1013 cases. Cefazolin was administered for antibiotic prophylaxis in 986 women (97.3%).
Alternative antibiotics were used for 27 women (2.7%). The appropriate cefazolin dose based on weight (ie 3 g for weight ≥ 120 kg) was 
Microbiology results
S. aureus or beta-haemolytic streptococci were identified in the samples from 65 (2.9%) women (51 of which were S. aureus), anaerobes from 34 (1.5%), enteric Gram-negatives from eight (0.4%), and skin organisms from 10 (0.4%).
The distribution of pathogens was significantly different between women with BMI ≥ 30 and those with BMI < 30 at booking (F = 15.9, p < 0.001). In the obese group, 87 swabs were sent; the primary pathogen was S. aureus or beta-haemolytic streptococcus in 37% (n = 32), anaerobic organisms in 25% (n = 22) and other organisms in 14% (n = 12); the remaining 24% (n = 21) had no growth. In the BMI < 30 group, 75 swabs were sent; the primary pathogen was S. aureus or beta-haemolytic streptococci in 43% (n = 32), anaerobic organisms in 16% (n = 12) and other organisms in 8% (n = 6); the remaining 33% (n = 25) had no growth.
Assessment of simplified surveillance strategies
The three factors which were found to have significantly increased
ORs for CSSSI were obesity and either Māori or Samoan ethnicity.
Comparing collection of a swab (regardless of culture) with only swab showing significant growth, all of these factors showed similar, statistically significant ORs. When assessing only swabs yielding S. aureus or beta-haemolytic streptococci, obesity and Samoan ethnicity remained associated with significantly increased ORs for CSSSI; however, Maori ethnicity did not meet significance. Data are shown in Table 2 .
DISCUSSION
Based on the information available, the 7.2% 'swab-defined' and 5.2% culture-positive CSSSI rates at Wellington Hospital are comparable to local and international rates. 1,6,9,14-16,24 Most infections were superficial, with <1% requiring return to theatre or readmission.
Obesity is a major risk factor for CSSSI, with an OR of 4.1, similar to previous studies. [4] [5] [6] 8, 9 This group accounts for 25.9%
of the sample population. Infection rate increases with increasing obesity, with almost one in five women with BMI > 40 being affected. In our cohort, 5% (n = 111) of women had a booking BMI > 40.
There is no current consensus on optimal prophylactic antibiotic dosing in obese women. 25 The current local hospital guideline recommended weight-based dosing; correct dosing was achieved in 94.3% of cases. Correct BMI-based dosing was achieved in 74.1% of women and was more strongly associated with reduced CSSSI.
Changing from a weight to BMI based protocol would affect 23.1%
(n = 241) of women in our cohort (ie with BMI ≥ 30 but weight under 120 kg); this group comprised 44.6% of the women with wound infections. This change therefore has the potential to significantly cut-off values and generally include small, heterogeneous populations which may account for the discrepancy. A recent study has also shown a significant decrease in CSSSI in obese women with prophylactic administration of oral cephalexin and metronidazole for 48 h post-CS. 31 Further study is warranted.
The observed increased rate of SSI in Māori and Samoan women indicates a need to ensure that prevention interventions reach these groups. 32 One previous study from New Zealand has reported no increased risk of CSSSI in the Māori population, but was limited by small numbers. 6 Although this association remains when controlling for obesity, assessment of other confounding factors such as socioeconomic status, diabetes and smoking was beyond the scope of this study, and warrants further investigation.
We were not able to demonstrate any other significant maternal risk factors. Gestational diabetes was not found to be a significant predictor of infection, although previous studies have demonstrated a significant increase in SSI. 9 Our statistical power was potentially inadequate to demonstrate a significantly increased risk.
Pregnancy factors (prematurity, size of infant, multiple infants) were not found to be significantly associated with CSSSI. The data do not demonstrate any increased risk with emergency CSs. Previous studies have conflicting results, with some showing increased risk 5, 6 and others showing no increased risk.
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In 55% of cases the principle pathogen identified was either S. aureus or beta haemolytic streptococci. This definition of infection may be the closest definition likely to respond to perioperative interventions (including antibiotics) rather than wound care, based on the assumption that these organisms are more likely to be pathogens than wound colonisers. The principle organism identified was an anaerobic organism more frequently in obese women than non-obese women. We hypothesise that anaerobic growth is more likely to be prevented by improved post-operative wound care. We therefore speculate that prevention interventions will be most successful if they target the preoperative, intraoperative and post-operative stages of care, with focus in the obese population.
Surveillance is also crucial to ongoing improvement. This study has provided a narrative to help provide context to laboratorybased surveillance of CSSSI. This is a resource-light tool utilising data which is readily available in the hospital setting to provide retrospective surveillance. We will continue to monitor
Staphylococcus aureus culture-positive swabs as a surveillance tool as it is simple to perform and should provide a marker of success for antibiotic and skin preparation strategies. 
Information for action: looking forward
Several studies have demonstrated significant reduction in CSSSI with intervention bundles, including improved wound care as well as staff and patient education. 1, [14] [15] [16] The results of this study will form the basis for a targeted high-risk intervention strategy, in addition to general measures to reduce CSSSI for our population. Important elements of prevention that we plan to introduce include booking BMI-based antibiotic dosing, preoperative chlorhexidine skin preparation prior to theatre, abdominal pannus control in theatre and standardised wound care. Interventions will be assessed to ensure they are equitable, accessible and acceptable to Māori and Samoan women.
We observed that there is little standardisation in expected care of the CS wound once the woman leaves hospital, including choice of dressings and when the dressing should be changed.
There are also opportunities to standardise collection of wound swabs and when antibiotics should be given. We believe that better wound care will reduce the rate of CSSSI as judged by swab numbers and those with anaerobic growth. Women with high BMI are likely to benefit most from post-operative wound care improvements, which may include negative pressure wound therapy
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